Neuraxis, Inc.
NRXS
$6.04+0.00%
End of day · as of Aug 27, 2026, 12:25 AM ET
Mkt cap
$83.10M
EV/Sales
21.9
P/E ratio
N/A
FY2025 Revenue
$3.57M
EPS (TTM)
$-0.76
Gross Margin (FY2025)
84.23%
Profit Margin (FY2025)
-218.55%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Neuraxis, Inc. (NRXS) is a biotechnology company listed on AMEX.
Latest reported NRXS revenue for 2025-12-31 was $3.6M. Net income was -$7.8M. Revenue was up 32.9% from 2024-12-31 to 2025-12-31. NRXS currently screens at market cap $83.1M.
Use this NRXS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full NRXS income, balance, and cash tables.
† Total Debt: Derived from short-term debt only (no total or long-term debt stored).
Neuraxis, Inc. (NRXS) is a biotechnology company in the Healthcare sector.
Latest cached Neuraxis, Inc. (NRXS) revenue for Dec 31, 2025 was $3.6M. Net income was -$7.8M. Statements: https://lician.com/financials/nrxs
Neuraxis, Inc. (NRXS) market capitalization is $83.1M on the latest cached snapshot.
Neuraxis, Inc. (NRXS) cached previous close $6.04; day range $5.98 – $6.20; volume 64,478. Session quote: https://lician.com/quote/nrxs
Neuraxis, Inc. (NRXS) latest cached earnings event is "NRXS earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached NRXS filing is 8-K · Oct 14, 2026. Filings: https://lician.com/sec/nrxs